当前位置:首页 - 行情中心 - 博雅生物(300294) - 财务分析 - 现金流量表

博雅生物

(300294)

  

流通市值:131.36亿  总市值:131.36亿
流通股本:5.04亿   总股本:5.04亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金871,330,951.42408,351,390.041,602,340,771.621,185,436,041.68
  收到的税费返还-25,856.826,278,811.17-
  收到其他与经营活动有关的现金29,841,503.2818,818,375.8975,227,937.158,485,388.52
  经营活动现金流入小计901,172,454.7427,195,622.751,683,847,519.891,243,921,430.2
  购买商品、接受劳务支付的现金362,939,888.99195,595,093.65473,437,861.94333,849,059.06
  支付给职工以及为职工支付的现金204,998,492.12121,993,991.48299,372,152.6218,232,785.86
  支付的各项税费106,241,298.8940,660,974.78173,334,880.74126,079,674.63
  支付其他与经营活动有关的现金220,046,405.38111,065,059.46437,921,367.72303,351,256.86
  经营活动现金流出小计894,226,085.38469,315,119.371,384,066,263981,512,776.41
  经营活动产生的现金流量净额6,946,369.32-42,119,496.62299,781,256.89262,408,653.79
二、投资活动产生的现金流量:
  收回投资收到的现金2,232,899,001.821,430,000,0006,506,005,0504,680,005,050
  取得投资收益收到的现金29,224,495.9120,136,918.4191,259,626.1266,996,252.14
  处置固定资产、无形资产和其他长期资产收回的现金净额1,706,908.5233,7281,821,936.891,287,064.06
  处置子公司及其他营业单位收到的现金净额--239,607,090.61109,429,245
  收到的其他与投资活动有关的现金--20,000,00020,000,000
  投资活动现金流入小计2,263,830,406.251,450,170,646.416,858,693,703.624,877,717,611.2
  购建固定资产、无形资产和其他长期资产支付的现金281,267,931.04119,475,659.29197,794,028.46119,280,768.2
  投资支付的现金2,200,000,0002,000,000,0005,530,496,527.84,630,000,000
  取得子公司及其他营业单位支付的现金--1,777,936,924.13-
  支付其他与投资活动有关的现金---182,000,000
  投资活动现金流出小计2,481,267,931.042,119,475,659.297,506,227,480.394,931,280,768.2
  投资活动产生的现金流量净额-217,437,524.79-669,305,012.88-647,533,776.77-53,563,157
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金--5,237,675.715,237,675.71
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--5,237,675.715,237,675.71
  偿还债务支付的现金--73,995,86022,145,000
  分配股利、利润或偿付利息支付的现金80,679,798.08-232,409,473.2151,274,621.4
  支付其他与筹资活动有关的现金3,476,007.111,696,873.992,306,484.82,028,702.8
  筹资活动现金流出小计84,155,805.191,696,873.99308,711,818175,448,324.2
  筹资活动产生的现金流量净额-84,155,805.19-1,696,873.99-303,474,142.29-170,210,648.49
四、汇率变动对现金及现金等价物的影响-7,950.9210,387.36-6,966.5
五、现金及现金等价物净增加额-294,654,911.58-713,110,996.13-651,226,662.1738,641,814.8
  加:期初现金及现金等价物余额1,298,571,389.971,298,571,389.971,949,798,052.141,949,798,052.14
  期末现金及现金等价物余额1,003,916,478.39585,460,393.841,298,571,389.971,988,439,866.94
补充资料:
  净利润225,409,614.24-396,528,491.41-
  资产减值准备9,662,728.44-83,825,238.02-
  固定资产和投资性房地产折旧51,790,115.9-78,232,929.44-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧51,790,115.9-78,182,591.43-
    投资性房地产折旧--50,338.01-
  无形资产摊销24,750,166.98-21,639,939.76-
  长期待摊费用摊销6,133,291.26-13,927,589.52-
  递延收益摊销---4,010,596.08-
  处置固定资产、无形资产和其他长期资产的损失-5,280,299.53-611,748.07-
  固定资产报废损失263,920.03-132,144-
  公允价值变动损失-37,004,306.86--65,582,550.87-
  财务费用454,554.7--1,929,280.58-
  投资损失-2,529,169.37--13,061,606.76-
  递延所得税6,722,503.98--6,223,228.54-
  其中:递延所得税资产减少-3,592,418.83--5,528,237.65-
    递延所得税负债增加10,314,922.81--694,990.89-
  存货的减少-23,694,524--120,059,964.7-
  经营性应收项目的减少-239,741,023.85--211,491,523.01-
  经营性应付项目的增加-12,013,108.27-116,589,093.05-
  现金的期末余额1,003,916,478.39-1,298,571,389.97-
  减:现金的期初余额1,298,571,389.97-1,949,798,052.14-
  现金及现金等价物的净增加额-294,654,911.58--651,226,662.17-
公告日期2025-08-232025-04-252025-03-192024-10-25
审计意见(境内)标准无保留意见
TOP↑